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Synopsis: This commentary proposes advances in research on abortion necessary 
for addressing the health and wellbeing of populations and meeting the UN 
Sustainable Development Goals.   
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Abstract 
Provision of safe abortion is widely recognized as vital to addressing the health and 
wellbeing of populations. Research on abortion is essential to meet the UN 
Sustainable Development Goals. We brought together researchers in population 
health from university, policy and practitioner contexts working on two 
multidisciplinary projects on family planning and safe abortion in Africa and Asia for a 
workshop to discuss the future research agenda on abortion. Research on care 
seeking behavior, supply of abortion care services, and the global and national policy 
context will help improve access to and experience of safe abortion services. A 
number of areas have potential in designing intervention strategies, including clinical 
innovations, quality improvement mechanisms, community involvement, and task 
sharing. Research on specific groups, including adolescents and young people, men, 
populations affected by conflict, marginalized groups, and providers, may increase 
our understanding of provision, access to and experiences of abortion. 
Methodological and conceptual advances, for example in measurement of abortion 
incidence and complications and client satisfaction, conceptualizations of abortion 
access and care, and methodologies to follow women who have abortions, will 
improve the accuracy of our measurements of abortion, and add to our 
understanding of women's experiences of abortion and abortion care. 
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Setting the research agenda for abortion in Africa and Asia 
Research on abortion is essential if we are to meet the UN Sustainable Development 
Goals (SDGs) [1]. Abortion is an important cause of maternal mortality: not only does 
unsafe abortion account for nearly one-fifth of all maternal deaths worldwide but 
complications of abortion increased as a proportion of causes of maternal deaths 
between 1990 and 2015 [2].Unsafe abortion has economic costs for health systems, 
women and their families [3,4], as well as social costs, for example through stigma 
experienced by women and their families, or the impact on family members of death 
or severe morbidity from abortion [4]. Provision of safe abortion is widely recognized 
as vital to addressing the health and wellbeing of populations [4]. Research on 
abortion can contribute to multiple SDGs including those relating to health and 
wellbeing, gender equality and poverty reduction. 
Research on abortion is particularly crucial in the context of the hostile policy 
environment created by the reinstatement of the US government’s Mexico City Policy 
which forbids foreign non-governmental organizations receiving US government 
money from providing or providing information about safe abortion services [5]. This 
has implications for provision and research on family planning in general and 
abortion in particular. An analysis of Demographic and Health Survey data showed 
that the reinstatement of the Mexico City Policy by the George W Bush 
administration in 2004 led to an increase in abortion rates in sub-Saharan Africa [6]. 
The policy’s reinstatement and even stricter interpretation by the Trump 
administration in 2017 has already had marked effects on the willingness of 
policymakers and stakeholders to enact globally agreed reproductive health 
strategies in some African settings [7]. Its further effects on abortion and family 
planning access remain to be studied. 
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Although use of modern methods of family planning has increased substantially in 
many low- and middle-income countries over the last decade, unmet need remains 
high and the number of women wanting to regulate their fertility is increasing [8]. 
There has been a decline in estimated abortion rates in high-income countries, yet 
estimated rates are stable or even increasing in Africa and Asia [9].  
The availability of medical abortion (MA) has revolutionized the way abortion 
services are provided, and has improved access to abortion. In low-resource settings 
with few trained surgical providers, MA provides a safe and effective non-surgical 
option [10]. MA drugs are widely available from pharmacies and drug sellers; even in 
restrictive settings, medication such as misoprostol can be purchased over the 
counter for other indications and used to induce an abortion [11]. This change in the 
way abortions are taking place also brings about many new research questions as 
well as a need for new methodological approaches. 
We brought together population health researchers from university, policy and 
practitioner contexts working on two multidisciplinary DFID-funded projects on family 
planning and safe abortion in Africa and Asia for a workshop to discuss the future 
research agenda on abortion in these geographic areas. Workshop attendees 
included academics researching – broadly – access to abortion services, quality of 
abortion care and measurement of abortion; researchers from organizations 
providing reproductive health services, with expertise in implementing and evaluating 
interventions; and individuals with expertise in reproductive health policy and 
programming. The Strengthening Evidence for Programming on Unintended 
Pregnancy (STEP-UP) project is a six year research consortium aiming to generate 
policy-relevant research for improving access to family planning and safe abortion 
services to reduce unintended pregnancy in five countries in Africa and South Asia 
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(http://stepup.popcouncil.org). Eva-PMDUP was an evaluation of the Prevention of 
Maternal Deaths and Unwanted Pregnancies (PMDUP) program implemented in 
fourteen countries in Africa and Asia between 2011 and 2016 
(http://mnhgroup.lshtm.ac.uk/eva-pmdup). These two projects cumulatively gathered 
a wealth of information about family planning and abortion. As the projects came to a 
close, the research teams took the opportunity to share lessons learned and insights 
about where the research agenda should go from here. The meeting focused on 
abortion: while contraception helps avoid unintended pregnancies, the emphasis of 
the workshop was on the women who have unintended pregnancies and their care 
pathways.  
The meeting covered three broad, but complementary, strands: Access, Quality and 
Policy. Participants presented research questions arising from the two projects. 
Research questions were drawn not solely from the findings of projects, but also 
from participants’ reflections on their research experiences during the projects, and 
supported by their reading of the current research literature. Subsequently, in small 
groups, participants discussed the research questions presented, and reflected on 
the novelty, feasibility and public health impact of each of the specific research 
questions raised, as well as their relevance to the SDGs, key audiences and policy 
and programmatic implications. Each small group fed back the key points of their 
discussion to the whole group. The group assembled considered each research 
question against the criteria above, in an effort to reach a group consensus on key 
themes within the research questions identified. To qualify for inclusion, it was not 
necessary that each research question fulfil all these criteria, but rather the criteria 
were cumulatively weighted against each other. For example, some of the questions 
included may present substantial methodological challenges, but were considered to 
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have significant public health implications if they could be addressed, whilst others 
may have less public health impact but would be straightforward and time-efficient to 
address. References included below rely heavily on the publications which came out 
of both the STEP-UP and Eva-PMDUP projects.  
We discuss the key research questions identified during the workshop below.  
1. What do we need to know to improve access to and the quality of 
comprehensive abortion services?  
In order to develop programs to reduce recourse to unsafe abortion and its 
consequences, it is necessary to understand barriers and facilitators to the use of 
safe abortion services. Abortion services comprise both safe abortion care (SAC) 
and post-abortion care (PAC). Together, these packages of services are called 
comprehensive abortion care (CAC). In restrictive settings, services mostly comprise 
PAC [12]. 
1.1 Factors shaping care-seeking behavior  
We identified many research gaps in factors that affect women’s abortion care-
seeking behaviors. For example, even in less-restrictive contexts, knowledge of the 
legal grounds under which an abortion may be obtained and where abortion services 
(including medical abortion) can be safely obtained can be very incomplete [13,14]. 
Family members’ lack of support can limit women’s choices [15], and gender 
inequality in addition to cultural stigma may restrict access to available abortion 
services [16]. Delays in identifying and confirming a pregnancy may prevent 
women’s timely access to abortion services [17]. Women may experience abortion 
symptoms differently, particularly after medical abortion, and may understand side-
effects differently as well as define morbidity differently, leading to differences in 
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post-abortion care-seeking behaviors. Further research into determinants of care-
seeking behavior will help inform interventions to improve access to services for 
those that need abortion care.  
1.2 Supply of abortion care services 
More research is needed on the availability, quality and outcomes of services and 
how these might be improved. Little is known about who is providing abortion 
services and how they are providing those services outside formal health services, or 
the safety of the services being provided within facilities in contexts with fragile 
healthcare systems, provider shortages and inadequate supply chains. Evidence 
suggests that there is increasing use of MA drugs purchased in the informal sector 
and in some middle-income countries, the internet, but there are limited data on this 
[18–20]. In addition, little is known about outcomes for individuals who self-manage 
medical abortion [21]. Our work suggests that information provided by pharmacies 
and drug sellers might be insufficient with regard to the correct regimen and the 
warning signs that should prompt medical treatment [22,23] (Box 1). Hostility on the 
part of pharmacy workers [19] and demands for excessively high medical provider 
fees [24] have also been documented, including fees for services that should be free 
of charge [25]. This has also been documented in public and teaching as well as 
private hospitals [24]. It is likely that providers do this when they perceive the woman 
to be willing to pay because the provider perceives her as someone vulnerable to 
exploitation, either because she does not know that the services should be free or 
because she is attempting to circumvent the law to protect her secrecy and 
potentially avoid social stigma for having an abortion. Unregulated clinics and 
alternative medical practitioners are popular among many women in some countries 
[26], and more research is needed to understand why women choose these 
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providers in settings where safe services are provided, and the quality of care they 
receive.  Post-abortion contraceptive use is low, whether the client obtained a 
surgical abortion in a health facility or a medical abortion in the community [27]. 
Qualitative research is needed to explore women’s experiences of and satisfaction 
with post-abortion contraceptive services, including the quality of counselling, to 
identify what might be most effective in delivering both post-abortion contraception 
and post-abortion contraceptive counselling in different settings (e.g. community, 
clinic, hospital).  
1.3  Interface between demand and supply 
Links between demand and supply of abortion care need to be investigated: how 
services fit into women’s lives, and how perceptions of quality and risk determine use 
of abortion care services. Access to and use of abortion services and post-abortion 
care may be a function of quality of care (e.g. waiting times, provider attitudes, 
privacy). It may be possible to link a quality score of a facility to a score of 
geographical access to a facility, in order to identify barriers to service use that are 
related to quality. It is important to understand the economic cost of abortion for 
individuals and families, particularly how they gather the financial resources to pay 
for an abortion, how this affects their timely access to abortion care, and the longer-
term implications for them of the financial outlay [28]. The relationship between 
expansion of medical abortion and availability should be examined.  
1.4  National and global policy context  
The Eva-PMDUP project conducted an in-depth policy analysis in multiple countries, 
three of which have been published so far [7,29,30].  There are a number of 
questions remaining about how national and global policy contexts determine 
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availability, use and experiences of abortion services. How do anti-choice groups, 
which have recently consolidated transnational advocacy networks and political 
blocs in international spaces, influence policy debates and popular discourse in 
different settings and what strategies do they use [5]? How do the global and 
national policies related to public, private and NGO sectors’ provision of abortion and 
the distribution of medical abortion drugs online and in informal markets affect 
women’s access and experiences of an induced abortion? These questions are 
particularly pertinent now given President Trump’s re-instatement of the Mexico City 
Policy. 
 
2. Which areas should be the focus of intervention? 
We identified a number of interventions that may help reduce recourse to unsafe 
abortion and improve quality of abortion care. 
2.1 Clinical innovations 
Evaluations of clinical innovations are needed to inform the evidence base on 
effective service delivery. These might include cervical priming, pain management in 
later trimester abortions, and self-administered DMPA (Sayana Press) learned at the 
time of abortion. Improving access to home pregnancy testing to enable women to 
confirm pregnancy at earlier gestations, which is associated with fewer complications 
[17,31] could lead to a reduction in  abortion morbidity and mortality.  
2.2 Quality improvement mechanisms  
Audits of deaths or near-miss mortality related to abortion may help elucidate where 
there are deficiencies in good quality abortion care and how these could be 
addressed (Box 2), possibly using a modified version of the three delays model [32] 
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(see 4.2 below). Quality improvement interventions should also focus on respectful 
care (see 4.3 below), and may look to the field of maternity care for suggestions of 
how this could be achieved. A key area for quality improvement is in how best to 
deliver post-abortion contraceptive counselling. Our work has found that provision of 
information on post-abortion contraception by pharmacists and drug sellers is low 
[33], and little is known about how best to deliver post-abortion contraception among 
women who purchase medical abortion drugs from these sources. Another issue is 
how best to integrate services, for example care for victims of sexual and gender-
based violence, with abortion care.  
2.3 Community involvement  
Research is needed to explore which elements of community involvement in 
planning, delivering and evaluating reproductive health services best improve access 
to and quality of abortion care. Examples of possible forms of community 
involvement include participatory learning and action techniques where communities 
and key stakeholders such as service providers work to identify and prioritize 
problems, develop and implement plans to address them, evaluate the result, and 
identify what course of action to take to continue to improve the situation [34]. Other 
options include inviting members of the community to participate in discussions 
about how to improve services. This is important to study carefully because of the 
sensitivities involved in this area.  
2.4 Task-sharing 
Even in countries where abortion is legal, provision is limited by a lack of trained 
providers. Task-sharing in abortion care including management of abortion and post-
abortion care, management of minor complications, and post-abortion contraceptive 
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counselling and provision has the potential to improve both access to and 
acceptability of abortion services. Some task-sharing in abortion services is already 
recommended by the WHO [21], but more rigorous research is needed to assess the 
safety, feasibility and acceptability of task-sharing of first trimester abortion services 
to lay health workers, pharmacists, pharmacy workers, and women themselves. 
 
3. How can research on specific groups increase our understanding of 
abortion?   
Some specific groups are particularly important for research on abortion, either 
because they are marginalized with regard to access to care, or because they play a 
role in shaping access to and experiences of abortion.  
3.1 Adolescents and young people 
Our research has highlighted the need to improve adolescents’ and young people’s 
access to abortion care [35]. To do this, we need to better understand their pathways 
to access (or failure to access) services, and the potential impact of medical abortion 
to change adolescents’ and young people’s access to abortion in restrictive legal 
contexts [36].  
3.2 Men 
Many women experience relationship problems as a result of unintended pregnancy 
or abortion, often with the partner denying paternity or refusing involvement [15]. 
Future research could explore men’s perceptions of responsibility for abortion, as 
well as understanding contexts where men are currently engaged and evaluating 
interventions that engage with men in the provision of abortion.  
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3.3 Populations affected by conflict 
The health of women fleeing war or natural disasters is particularly threatened by 
weak sexual and reproductive health services, as well as gender-based and sexual 
violence [37]. Service provision changes rapidly as regions move in and out of 
different phases of armed conflict, as may political discourses about gender, 
reproduction and the legitimacy of different categories of providers which affects 
supply [29]. More research is needed on both demand for and opportunities to 
provide quality abortion care in crisis situations, including how best to reach mobile 
populations.  
3.4 Marginalized groups 
Marginalized people are not necessarily those who live in poorer households, and 
those who do not access services are not necessarily those living in poorer areas of 
the country. Future research might explore abortion in the context of different 
conceptualizations of vulnerability and marginalization, for example marginalization 
in terms of ethnicity, legal status, geography, marital status, age or disability [38] to 
improve understanding of barriers to safe abortion care. 
3.5 Providers 
Health care providers have a crucial role to play in the availability and quality of 
abortion care. Limited research has examined the experiences of the individuals who 
provide abortion care, and the stigma and professional challenges they may 
experience. Studies suggest that providers often have reservations about providing 
abortion care [39], and mechanisms to help providers to cope with stigma and stress 
are urgently needed. Further research is needed to understand how best to do this, 
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and to evaluate the impact on provider and client experiences, and quality of care, of 
interventions to support abortion providers.  
 
4. How might methodological or conceptual advances improve our 
understanding of safe provision of abortion and women’s experiences of 
abortion? 
Abortion is a sensitive topic and both women and providers are often unwilling to 
participate in research. Innovations in the conceptualization and measurement of 
abortion are important in order to improve the accuracy of our measurements of 
abortion, and to add to our understanding of the quality of the abortion care that 
women receive.  
4.1 Measurement of abortion incidence and complications 
Without accurate measurement of the incidence of abortion and abortion 
complications, it is challenging to measure changes in abortion safety. In surveys, 
careful wording of questions and use of more private interview methods such as 
audio computer assisted self-interview (ACASI) might improve reporting by women 
who have had abortions [40]. Inclusion of abortion questions in innovative ways 
(such as asking about abortion along with a long list of other medical care) may also 
increase abortion reporting. Using near-miss cases (women who have had very 
severe complications from abortion, with a high risk of death) has been shown to be 
a promising indicator of unsafe abortion, and depending on the quality of the medical 
records, can be measured using medical records data [41]. There is likely to be a 
reduction in severe morbidity from abortion complications as medical abortion 
becomes more widespread. Other ways of measuring abortion incidence include the 
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Confidants Method [42], which can reduce reporting bias as women speak about the 
abortion experience of friends or family members, rather than themselves. 
Respondent driven methodologies, which combine snowball sampling with a 
mathematical model to account for the fact that the sample was collected in a non-
random way [43], can also shed light on abortion incidence and care-seeking.  
4.2 Three delays model adaptation 
The three-delays model [32] identifies three main factors that prevent women from 
accessing care: delays in seeking care, delays in reaching care and delays in 
receiving adequate care. An adaptation of this to abortion care may be a useful 
overarching framework for understanding abortion care-seeking behavior and 
identifying areas for research and intervention.  
4.3 Respectful care model adaptation 
The model of respectful care, that is that maternal care should be humane and 
dignified, and be expanded beyond the prevention of morbidity or mortality to include 
respect for women’s fundamental human rights, is becoming more recognized in 
maternal health [44]. Adaptation of this model for abortion research may be useful in 
identifying areas for improvement.   
4.4 Methodologies to follow women who use drug sellers 
Reporting the outcomes of women who use medical abortion purchased from 
pharmacies and drug sellers has presented significant measurement challenges as 
identifying, recruiting and following up these women is difficult [45]. This is evidenced 
in our research in Bangladesh, where we conducted a prospective cohort study of 
women using menstrual regulation medications purchased from pharmacies [22]. 
New methodologies need to be tested such as recruiting using research assistants 
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based in pharmacies or offering financial incentives to providers to improve 
recruitment, or the use of mobile phone technologies to improve retention.  
4.5 Developing measures of client satisfaction 
Client satisfaction is a useful measure of service quality but is frequently measured 
using exit interviews, which are prone to courtesy bias [46]. New ways of measuring 
client satisfaction might provide a more accurate indicator of quality of care (Box 3).   
4.6 Mobile phone technologies  
Mobile phones may have the potential to improve both supply (for example, 
supporting pharmacists in their provision of medical abortion by giving them easy to 
access information or by allowing providers to request medical abortion or manual 
vacuum aspiration equipment via mobile applications) and demand-side factors (for 
example, by measuring client satisfaction by SMS or providing information on 
instructions for use of medical abortion, through providing information and reminders 
about follow-up care post-abortion or post-abortion contraception) of abortion care 
[47].  
Conclusion 
The research themes we identify cohere with the agenda put forward following the 
Africa Regional Conference on Abortion (November 29th-December 2nd 2016, Addis 
Ababa, Ethiopia)[48], which calls for an expansion of the evidence base to inform 
better policies and programs. This agenda highlights many similar research areas of 
importance, including: abortion stigma, the social and economic barriers individuals 
face in accessing safe abortion, the potential for task sharing, measuring quality of 
abortion services, and the needs of survivors of violence including those in 
humanitarian settings.   
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The research questions we propose highlight the need to understand the 
determinants of demand for abortion care, how availability and quality might be 
improved, and the interface between demand and supply. Improving access to and 
quality of abortion care will reduce maternal mortality from complications of unsafe 
procedures. Developing new technologies may help empower women to self-
manage medical abortion. Finally, individuals must have full bodily autonomy to 
regulate their fertility, pursue opportunities for education and employment, and  
achieve overall health, wellbeing and productivity [49]. Research addressing these 
themes will be essential to meeting the SDGs. We issue a call to all researchers to 
participate in working to answer these pressing questions so that the next generation 
of women will not experience the same levels of morbidity and mortality from unsafe 
abortion as this generation.   
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Box 1 
Pharmacy provision of medical abortion is likely to continue to expand, and has the 
potential to reduce mortality and morbidity associated with unsafe abortion. 
However, studies suggest that in both Africa and Asia, ineffective medications are 
often sold, and information on the correct drug regimen and advice in the event of 
complications provided by drug sellers is often poor [11,22,23,50,51]. To further 
reduce harm from unsafe abortion, research is needed on both the outcomes of 
women who self-manage medical abortion and ways to improve women’s 
experiences of self-management of medical abortion. These might include training 
for drug sellers, improvements to packaging of the drugs, and hotlines for information 
provision [50].  
Box 2 
Audits are frequently used in maternal health as a monitoring tool to identify areas of 
care that can be improved, develop recommendations and monitor improvements 
[52]. Audits have been successful in helping to reduce childbirth-related deaths in 
low-income countries [53]. In contexts where mortality from abortion is high, such as 
Zambia, audits of death or near-miss mortality from abortion, using hospital-based 
surveillance infrastructure, may help understand where there are deficiencies in 
good quality abortion care and how these could be addressed in order to reduce 
unsafe abortion. In contexts where abortion mortality is low, such as India, 
surveillance structures may be better placed in the community and the informal, 
private sector.  
Box 3 
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Novel ways of measuring client satisfaction as a measure of service quality might 
include formative research to identify constructs of dis/satisfaction in the context of 
abortion services; modelling the effects on non-response bias in follow-up services 
and developing techniques to reduce non-response and/or adjust for it; and exploring 
the potential for the use of ACASI surveys in centers to measure client satisfaction. 
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